Association of Renal Resistive Index with Target Organ Damage in Essential Hypertension
Overview
Authors
Affiliations
Background: The renal resistive index (RI) measured using Doppler ultrasonography has been used as a diagnostic tool in the daily work-up of kidney diseases. A better understanding of its relationship with preclinical organ damage may help in determining overall cardiovascular risk in hypertensive patients.
Methods: We evaluated the association between RI and the presence and degree of target organ damage (TOD) in 288 (130 male) essential hypertensive patients. RI, carotid intima-media thickness (IMT), and left ventricular (LV) mass index were assessed by ultrasound scan. Albuminuria was measured as the albumin-to-creatinine ratio (ACR) in three consecutive first morning urine samples.
Results: In univariate analysis, patients with TOD showed significantly higher RI as compared with those without TOD (presence vs. absence of carotid wall thickening, LV hypertrophy, and albuminuria, P < 0.01, respectively). The severity of each TOD increased progressively from the lower to the upper RI tertile. Multiple logistic regression analysis found that each standard deviation increase in RI gave a 47% higher odds of having LV hypertrophy, and a 70% higher odds of having albuminuria (P < 0.05, respectively). The occurrence of at least two signs of TOD also significantly increased in parallel with elevation of RI (odds ratio (OR): 1.89 for 1 s.d. increase, P < 0.01).
Conclusions: These results suggest that increased RI may be a marker of subclinical TOD in patients with essential hypertension.
Carollo C, Vadala M, Sorce A, Sinatra N, Orlando E, Cirafici E Biomedicines. 2025; 13(2).
PMID: 40002725 PMC: 11853031. DOI: 10.3390/biomedicines13020312.
Renal Arterial and Venous Doppler in Cardiorenal Syndrome: Pathophysiological and Clinical Insights.
Barone R, Terlizzi V, Goffredo G, Paparella D, Brunetti N, Iacoviello M Biomedicines. 2024; 12(6).
PMID: 38927373 PMC: 11200488. DOI: 10.3390/biomedicines12061166.
Mancianti N, Tripodi S, Pascucci A, Calatroni M, La Porta E, Guarnieri A J Clin Med. 2024; 13(7).
PMID: 38610593 PMC: 11012688. DOI: 10.3390/jcm13071828.
Darabont R, Mihalcea D, Vinereanu D Diagnostics (Basel). 2023; 13(10).
PMID: 37238172 PMC: 10217442. DOI: 10.3390/diagnostics13101687.
Iwashima Y, Kusunoki H, Taniyama A, Horio T, Hayashi S, Kishida M J Am Heart Assoc. 2022; 11(6):e023655.
PMID: 35261276 PMC: 9075284. DOI: 10.1161/JAHA.121.023655.